Tech trend — Disruption score: 7.3/10
Mammalian synthetic gene circuits enabling programmable control over biopharmaceutical production — including antibody glycosylation, CAR-T safety switches, and viral vector yields — represent a genuine convergence of synthetic biology and therapeutic manufacturing with foundational scientific novelty.
Paradigm Shift detected
Loading…